0.3199
-0.0243 (-7.06%)
-0.0243 (-7.06%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 2,868,192 |
|
|||||
| News | - | ||||||
| Day High | 0.3476 | Low High |
|||||
| Day Low | 0.3102 | ||||||
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Advaxis Inc | ADXS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.0243 | -7.06% | 0.3199 | 00:00:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.3442 | 0.3102 | 0.3476 | 0.311 | 0.3442 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,412 | 2,868,192 | $ 0.3279393 | $ 940,593 | - | 0.30 - 1.57 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:45:09 | formt | 101 | $ 0.3199 | USD |
Period:
Draw Mode:
Advaxis Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 46.59M | 145.64M | 145.57M | $ 253.00k | $ - | -0.42 | -1.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 3.00% |
Advaxis News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ADXS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.3763 | 0.42 | 0.3102 | 0.3776924 | 3,722,917 | -0.0564 | -14.99% |
| 1 Month | 0.4991 | 0.5091 | 0.3102 | 0.4183122 | 4,425,298 | -0.1792 | -35.9% |
| 3 Months | 0.4799 | 0.645 | 0.3102 | 0.5079509 | 6,719,509 | -0.16 | -33.34% |
| 6 Months | 0.5035 | 0.71 | 0.3102 | 0.5063824 | 6,792,310 | -0.1836 | -36.46% |
| 1 Year | 0.32 | 1.57 | 0.30 | 0.6190608 | 9,388,902 | -0.0001 | -0.03% |
| 3 Years | 0.41 | 10.80 | 0.181 | 0.6469357 | 5,158,972 | -0.0901 | -21.98% |
| 5 Years | 8.32 | 10.80 | 0.181 | 0.9387692 | 3,412,342 | -8.00 | -96.16% |
Advaxis Description
| Advaxis Inc is a clinical stage biotechnology company operating in the United States. It focuses on the discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology which utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate Specific Antigen (PSA) associated with prostate cancer. |
